The capital region is one of the most important healthcare industry locations in Germany with 332 medical technology and 255 biotech companies, 34 pharmaceuticals companies, and more than 130 hospitals and clinics. Health promotion, disease prevention, and healthcare all benefit from the region's many organizations active in the healthcare economy and research.
World market leaders, renowned scientists, first-class clinics, innovative start-ups, and specialists from all over the world work together daily to deliver world-class services for the regional and global healthcare markets. The strengths of the region include especially the unique research and clinical landscape and the close networking between the worlds of research, clinical care, industry, politics, and professional associations. Also the key German interface to the IT industry, the capital region offers the best conditions for the development and application of digital health solutions.
“Our aspiration for Berlin must be both top research and the best healthcare. We have never been as well positioned in these areas as we are today. We are currently investing over two billion euros in modern infrastructure for the life and natural sciences at our universities, the Charité, and research institutes alone. €100 million biotech start-up centres are being created in Buch and Dahlem. With the Berlin Institute of Health and the Heart Centre, the federal government also relies heavily on Berlin as a centre for medical research and healthcare. But of course, the expansion of scientific research in Berlin in the next decade will cost hundreds of millions, if not more, in these areas alone.”
Michael Müller, Governing Mayor of Berlin (Source: Der Tagesspiegel)
Whether it's medical care, rehabilitation, or nursing, patients of all ages and from all over the world find efficient and well-networked medical care of the highest standard in Berlin-Brandenburg.
„In 2008 we very consciously decided in favor of Berlin, because we wanted to be closer to healthcare policy-makers. Moreover, the Berlin-Brandenburg region offers excellent biomedical research - you won't find a similar cluster of research facilities anywhere else in Germany. Having top-ranked research so close at hand is one of the signature features of the region. At the same time, a vibrant, international startup scene is emerging here that we find quite exciting. (...) And of course we also enjoy the city's vitality, international flavor and cultural diversity. Our employees really appreciate that, and we are glad to have found a home here in the heart of the city.“
Partners in the healthcare industry located in Berlin include: Legislators and government, leading associations, industry, cutting-edge research, clinics, health insurance and patient lobbying groups, training institutions, and innovative startups. Complementary fields such as IT, optics, and materials research are also concentrated in the capital region.
Facts & Figures:
- 34 pharmaceuticals companies with approx. 11,000 employees
- 255 biotech companies with approx. 6,200 employees
- 332 medical technology companies with approx. 14,400 employees
- more than 130 hospitals with more than 35,000 beds
- over 70 rehabilitation facilities, more than 800 nursing homes, more than 1,200 nursing services
- the Charité, one of the largest university hospitals in Europe
- the largest hospital laboratory in Europe: Labor Berlin - Charité Vivantes GmbH
- 8 technology parks focusing on the life sciences
(Source: Survey of Berlin Partner for Business and Technology, 2019)
Industry leaders headquartered in the capital region
Some 40 institutions conducting research in the life sciences are in the region, including the University Hospital Charité, the Brandenburg Medical School Theodor Fontane, the Berlin Institute for Health Research (BIH), and the Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association, the Robert Koch Institute, the German Heart Center Berlin, and other well-known Fraunhofer, Helmholtz, Leibniz, and Max Planck institutes in Berlin and Brandenburg.
Over 200 degree courses in health and life sciences at approx. 30 universities and colleges, including:
Gross value created by the industrial health business and its share in the health economy
In 2019, the gross value chain of the industrial health economy (IGW) in Berlin amounted to 20.1 billion euros and contributed 14.6% to the whole gross value chain of the health economy.
(Source of data illustration: Berlin Partner, Annual report 2020)